{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:36:12Z","timestamp":1777775772187,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302302\/2015-8"],"award-info":[{"award-number":["302302\/2015-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["PVE 401289\/2014-1"],"award-info":[{"award-number":["PVE 401289\/2014-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["401837\/2016-5"],"award-info":[{"award-number":["401837\/2016-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","award":["4785-14-2"],"award-info":[{"award-number":["4785-14-2"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.npep.2020.102059","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T20:22:27Z","timestamp":1592252547000},"page":"102059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effects of non-peptide nociceptin\/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders"],"prefix":"10.1016","volume":"82","author":[{"given":"Laila","family":"Asth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamella R.F.","family":"Tiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layse R.F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor A.D.","family":"Holanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurulain T.","family":"Zaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girolamo","family":"Calo'","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Ruzza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine C.","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2020.102059_bb0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neuropharm.2016.02.003","article-title":"Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin\/orphanin FQ receptor ligands","volume":"105","author":"Asth","year":"2016","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.npep.2020.102059_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1734-1140(11)70399-1","article-title":"Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania","volume":"63","author":"Barbosa","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.npep.2020.102059_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2020.102059_bb0020","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0196-9781(02)00102-X","article-title":"Lack of the nociceptin receptor does not affect acute or chronic nociception in mice","volume":"23","author":"Bertorelli","year":"2002","journal-title":"Peptides."},{"issue":"3","key":"10.1016\/j.npep.2020.102059_bb0025","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0306-4522(98)00683-6","article-title":"Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system","volume":"91","author":"Boom","year":"1999","journal-title":"Neuroscience."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0893-133X(95)00077-Q","article-title":"Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit\/hyperactivity disorder","volume":"14","author":"Castellanos","year":"1996","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.npep.2020.102059_bb0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.npep.2020.102059_bb0040","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/BF02532380","article-title":"Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ","volume":"21","author":"Devine","year":"1996","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.npep.2020.102059_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10519-006-9093-4","article-title":"Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease","volume":"37","author":"Einat","year":"2007","journal-title":"Behav. Genet."},{"key":"10.1016\/j.npep.2020.102059_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2016.10.025","article-title":"In vitro functional characterization of novel nociceptin\/orphanin FQ receptor agonists in recombinant and native preparations","volume":"793","author":"Ferrari","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.npep.2020.102059_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(96)00707-8","article-title":"Nociceptin stimulates locomotion and exploratory behaviour in mice","volume":"317","author":"Florin","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.npep.2020.102059_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pharmthera.2013.05.008","article-title":"Nociceptin\/orphanin FQ receptor antagonists as innovative antidepressant drugs","volume":"140","author":"Gavioli","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.npep.2020.102059_bb0065","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1046\/j.1460-9568.2003.02603.x","article-title":"Blockade of nociceptin\/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test","volume":"17","author":"Gavioli","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.npep.2020.102059_bb0070","first-page":"547","article-title":"Antidepressant-like effects of the nociceptin\/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs arch","volume":"369","author":"Gavioli","year":"2004","journal-title":"Pharmacol."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8","article-title":"Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder","volume":"105","author":"Greenwood","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.npep.2020.102059_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/acps.12408","article-title":"A systematic review and meta-analysis of premature mortality in bipolar affective disorder","volume":"131","author":"Hayes","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.npep.2020.102059_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0028-3908(01)00048-X","article-title":"Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function","volume":"41","author":"Higgins","year":"2001","journal-title":"Neuropharmacology."},{"issue":"11","key":"10.1016\/j.npep.2020.102059_bb0095","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1007\/s00213-018-5004-7","article-title":"NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine","volume":"235","author":"Holanda","year":"2018","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.npep.2020.102059_bb0100","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1177\/0269881119864942","article-title":"Modulation of the NOP receptor signaling affects resilience to acute stress","volume":"33","author":"Holanda","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"26","key":"10.1016\/j.npep.2020.102059_bb0105","doi-asserted-by":"crossref","first-page":"14854","DOI":"10.1073\/pnas.94.26.14854","article-title":"Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress","volume":"94","author":"Jenck","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2020.102059_bb0110","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"NC3Rs reporting guidelines working group, animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1073858411401413","article-title":"Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging","volume":"18","author":"Ko","year":"2012","journal-title":"Neuroscientist."},{"issue":"1","key":"10.1016\/j.npep.2020.102059_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bjp.0705906","article-title":"The NOP (ORL1) receptor antagonist compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism","volume":"143","author":"Koizumi","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00008877-200503000-00005","article-title":"Is the nociceptin (NOP) receptor involved in attenuation of the expression of sensitization to morphine-induced hyperlocomotion in mice?","volume":"16","author":"Kotlinska","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.npep.2020.102059_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.dhjo.2011.05.001","article-title":"WHO world report on disability: a review","volume":"4","author":"Krahn","year":"2011","journal-title":"Disabil. Health J."},{"issue":"8","key":"10.1016\/j.npep.2020.102059_bb0135","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrd2572","article-title":"The nociceptin\/orphanin FQ receptor: a target with broad therapeutic potential","volume":"7","author":"Lambert","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.npep.2020.102059_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130000609","article-title":"Orphanin FQ\/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats","volume":"154","author":"Lutfy","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.npep.2020.102059_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2013.03.021","article-title":"The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice","volume":"707","author":"Marquez","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.npep.2020.102059_bb0150","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1471-4159.2004.02843.x","article-title":"Blockade of nociceptin\/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release","volume":"91","author":"Marti","year":"2004","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/npp.2008.56","article-title":"Nociceptin\/orphanin FQ modulates motor behavior and primary motor cortex output through receptors located in substantia nigra reticulata","volume":"34","author":"Marti","year":"2009","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.npep.2020.102059_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2015.05.006","article-title":"Blockade of nociceptin\/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice","volume":"72","author":"Medeiros","year":"2015","journal-title":"Peptides."},{"issue":"3","key":"10.1016\/j.npep.2020.102059_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6549","key":"10.1016\/j.npep.2020.102059_bb0170","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.npep.2020.102059_bb0175","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/ajmg.b.30745","article-title":"Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3)","volume":"147B","author":"Mick","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"7","key":"10.1016\/j.npep.2020.102059_bb0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0196-9781(00)00227-8","article-title":"Tissue distribution of the opioid receptor-like (ORL1) receptor","volume":"21","author":"Mollereau","year":"2000","journal-title":"Peptides."},{"issue":"8","key":"10.1016\/j.npep.2020.102059_bb0185","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11920-015-0603-z","article-title":"Management of adverse effects of mood stabilizers","volume":"17","author":"Murru","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1139\/jpn.0413","article-title":"Orphanin FQ\/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats","volume":"29","author":"Narayanan","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"issue":"4","key":"10.1016\/j.npep.2020.102059_bb0195","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1096-9861(19991004)412:4<563::AID-CNE2>3.0.CO;2-Z","article-title":"Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding","volume":"412","author":"Neal","year":"1999","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.npep.2020.102059_bb0200","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/(SICI)1096-9861(19990419)406:4<503::AID-CNE7>3.0.CO;2-P","article-title":"Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat","volume":"406","author":"Neal","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2020.102059_bb0205","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/emboj\/16.8.1858","article-title":"Unrestrained nociceptive response and dysregulation of hearing ability in mice lacking the nociceptin\/orphaninFQ receptor","volume":"16","author":"Nishi","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.npep.2020.102059_bb0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jad.2011.04.055","article-title":"Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity","volume":"133","author":"Nivoli","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0215","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/npp.2017.155","article-title":"Antimanic efficacy of a novel Kv3 potassium channel modulator","volume":"43","author":"Parekh","year":"2018","journal-title":"Neuropsychopharmacology."},{"issue":"8","key":"10.1016\/j.npep.2020.102059_bb0220","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/npp.2011.45","article-title":"Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder","volume":"36","author":"Pinsonneault","year":"2011","journal-title":"Neuropsychopharmacology."},{"issue":"7","key":"10.1016\/j.npep.2020.102059_bb0225","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/npp.2015.348","article-title":"A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies","volume":"41","author":"Post","year":"2016","journal-title":"Neuropsychopharmacology."},{"issue":"5237","key":"10.1016\/j.npep.2020.102059_bb0230","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science."},{"key":"10.1016\/j.npep.2020.102059_bb0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuropharm.2017.07.006","article-title":"Activation of nociceptin\/orphanin FQ receptors inhibits contextual fear memory reconsolidation","volume":"125","author":"Rekik","year":"2017","journal-title":"Neuropharmacology."},{"issue":"3","key":"10.1016\/j.npep.2020.102059_bb0240","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/jpet.106.116780","article-title":"Pharmacological characterization of the nociceptin\/orphanin FQ receptor antagonist SB-612111 [(\u2212)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies","volume":"321","author":"Rizzi","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.npep.2020.102059_bb0245","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuropharm.2010.12.010","article-title":"Nociceptin\/orphanin FQ receptor knockout rats: in vitro and in vivo studies","volume":"60","author":"Rizzi","year":"2011","journal-title":"Neuropharmacology."},{"issue":"4","key":"10.1016\/j.npep.2020.102059_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.247","article-title":"Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin\/orphanin FQ and opioid receptor agonist","volume":"4","author":"Rizzi","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.npep.2020.102059_bb0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.peptides.2017.07.002","article-title":"Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test","volume":"94","author":"Rizzi","year":"2017","journal-title":"Peptides."},{"issue":"7","key":"10.1016\/j.npep.2020.102059_bb0260","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1021\/jm991129q","article-title":"High-affinity, non-peptide agonists for the ORL1 (orphanin FQ\/nociceptin) receptor","volume":"43","author":"R\u00f6ver","year":"2000","journal-title":"J. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.npep.2020.102059_bb0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2010.07.036","article-title":"Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats","volume":"645","author":"Rutten","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.npep.2020.102059_bb0270","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.mp.4001875","article-title":"Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes","volume":"11","author":"Ryan","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.npep.2020.102059_bb0275","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/mp.2008.29","article-title":"The genetics of bipolar disorder: genome \u2018hot regions,\u2019 genes, new potential candidates and future directions","volume":"13","author":"Serretti","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.npep.2020.102059_bb0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbr.2018.08.019","article-title":"Nociceptin\/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test","volume":"356","author":"Silva","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2020.102059_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2016.06.044","article-title":"Lithium and valproate prevent methylphenidate-induced mania-like behaviors in the hole board test","volume":"629","author":"Souza","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0290","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/Orphanin FQ receptor structure, signaling, ligands, Functions and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"1\u20133","key":"10.1016\/j.npep.2020.102059_bb0295","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejphar.2012.11.050","article-title":"Retrodialysis of N\/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity","volume":"699","author":"Vazquez-DeRose","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0300","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.expneurol.2010.01.014","article-title":"Dual motor response to l-dopa and nociceptin\/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: paradoxical inhibition is relieved by D(2)\/D(3) receptor blockade","volume":"223","author":"Viaro","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2020.102059_bb0305","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"4","key":"10.1016\/j.npep.2020.102059_bb0310","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/syn.890160402","article-title":"Imaging endogenous dopamine competition with [11C]raclopride in the human brain","volume":"16","author":"Volkow","year":"1994","journal-title":"Synapse."},{"issue":"10","key":"10.1016\/j.npep.2020.102059_bb0315","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","article-title":"Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate","volume":"155","author":"Volkow","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.npep.2020.102059_bb0320","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1471-4159.2010.07061.x","article-title":"Further evidence for an involvement of nociceptin\/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice","volume":"115","author":"Volta","year":"2010","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.npep.2020.102059_bb0325","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.jcp.0000237950.65517.be","article-title":"Manic\/hypomanic switch during acute antidepressant treatment for unipolar depression","volume":"26","author":"Wada","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"13","key":"10.1016\/j.npep.2020.102059_bb0330","first-page":"916","article-title":"Plasma levels of nociceptin\/orphanin FQ in patients with bipolar disorders and health adults","volume":"89","author":"Wang","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"16","key":"10.1016\/j.npep.2020.102059_bb0335","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0960-894X(99)00385-6","article-title":"8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists","volume":"9","author":"Wichmann","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.npep.2020.102059_bb0340","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1124\/jpet.103.055848","article-title":"Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (\u2212)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)","volume":"308","author":"Zaratin","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341792030072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341792030072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:14:43Z","timestamp":1777486483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014341792030072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":67,"alternative-id":["S014341792030072X"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2020.102059","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of non-peptide nociceptin\/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2020.102059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102059"}}